API

Levofloxacin hydrochloride (CAS No.: 100986-85-4) Mainly used for the synthesis of antibiotics, used in the treatment of respiratory tract, urinary tract and skin tissue infections.
Our company produces 15 tons of Levofloxacin hydrochloride (CAS No.: 100986-85-4) every month, adequate inventory.
Our company sells more than 20 tons of Levofloxacin hydrochloride (CAS No.: 100986-85-4) every year, mainly to the European and American markets and Southeast Asian markets, and has a good foundation for cooperation with many large multinational enterprises.

Our company produces 50KG/M of ((S)-2,2-dimethyl-1,3-dioxolan-4-yl)methyl 3-(4-(((S)-oxiran-2-yl)methoxy)phenyl)propanoate (CAS No.: 144256-12-2) every month, adequate inventory.

Our company sells more than 50KG/M of ((S)-2,2-dimethyl-1,3-dioxolan-4-yl)methyl 3-(4-(((S)-oxiran-2-yl)methoxy)phenyl)propanoate (CAS No.: 144256-12-2) every year, mainly to the European and American markets and Southeast Asian markets, and has a good foundation for cooperation with many large multinational enterprises.

Imidocarb dipropionate (CAS No.: 55750-06-6) is a new type of animal specific antigenic insect chemical drugs.
Our company produces 5000 kg of Imidocarb dipropionate (CAS No.: 55750-06-6) every month, adequate inventory.
Our company sells more than 5000 kg of Imidocarb dipropionate (CAS No.: 55750-06-6) every year, mainly to the European and American markets and Southeast Asian markets, and has a good foundation for cooperation with many large multinational enterprises.

LOXO-101 (CAS No.: 1223405-08-0) is the organic synthesis intermediates and pharmaceutical intermediates.
Our company produces 3000 kg of LOXO-101 (CAS No.: 1223405-08-0) every month, adequate inventory.
Our company sells more than 3000 kg of LOXO-101 (CAS No.: 1223405-08-0) every year, mainly to the European and American markets and Southeast Asian markets, and has a good foundation for cooperation with many large multinational enterprises.

Alpelisib (BYL719) (CAS No.: 1217486-61-7) is a kinase inhibitor.
Our company produces 300 kg of Alpelisib (BYL719) (CAS No.: 1217486-61-7) every month, adequate inventory.
Our company sells more than 300 kg of Alpelisib (BYL719) (CAS No.: 1217486-61-7) every year, mainly to the European and American markets and Southeast Asian markets, and has a good foundation for cooperation with many large multinational enterprises.

Tucatinib (CAS No.: 937263-43-9) is a kinase inhibitor.
Our company produces 100 kg of Tucatinib (CAS No.: 937263-43-9) every month, adequate inventory.
Our company sells more than 300 kg of Tucatinib (CAS No.: 937263-43-9) every year, mainly to the European and American markets and Southeast Asian markets, and has a good foundation for cooperation with many large multinational enterprises.

TAS6417 (CAS No.: 1661854-97-2) is a novel EGFR inhibitor that targets EGFR mutants and is less effective against wild-type EGFR.
Our company produces 100KG/M of TAS6417 (CAS No.: 1661854-97-2) every month, adequate inventory.
Our company sells more than 100KG/M of TAS6417 (CAS No.: 1661854-97-2) every year, mainly to the European and American markets and Southeast Asian markets, and has a good foundation for cooperation with many large multinational enterprises.

1.2- deoxy -D- glucose is a derivative of D- glucose. It is an anti metabolite. It is also an important component of positive adhesion virus, paramyxovirus and herpes virus envelope. It interferes with the synthesis of virus specific glycoprotein, and can effectively inhibit herpes simplex virus, RNA and DNA envelope virus, breast cancer cell proliferation and so on. The antiviral and anticancer drugs made from 2- deoxy -D- glucose to Chemicalbook have been used in clinical treatment of herpes simplex virus, influenza, AIDS and cancer. Anti aging cosmetics and health care products made from 2-deoxy-D-glucose are also on the market. Therefore, 2-deoxy-D-glucose, as a drug for the treatment of cancer, viral diseases and anti-aging, has broad application prospects and huge market demand.


2,Our company produces 3000 tons of 2-Deoxy-D-glucose CAS154-17-6every year, and its production capacity ranks the top three in China


3.Our company sells more than 3000 tons of2-Deoxy-D-glucose CAS154-17-6every year, mainly to the European and American markets and Southeast Asian markets, and has a good foundation for cooperation with many large multinational enterprises

LOXO-292 (CAS No.: 2222755-14-6) is a potent, oral, highly selective rearrangement during transfection (RET) kinase inhibitor for the treatment of cancer patients with abnormal RET.
Our company produces 50KG/M of LOXO-292 (CAS No.: 2222755-14-6) every month, adequate inventory.
Our company sells more than 50KG/M of LOXO-292 (CAS No.: 2222755-14-6) every year, mainly to the European and American markets and Southeast Asian markets, and has a good foundation for cooperation with many large multinational enterprises.